Professional Experience
Ms. Ingargiola provides strategic and regulatory advice, policy analysis and project support to pharmaceutical and biotechnology companies, healthcare providers and other healthcare clients on Medicare regulatory and reimbursement, health information technology and other issues.
Prior to joining Manatt Health Solutions, Ms. Ingargiola worked for Amylin Pharmaceuticals, a biotechnology company located in San Diego, California, where she was Associate Director for Public Policy and a founding member of the company’s Government Affairs Department. While at Amylin, Ms. Ingargiola served as the company’s lead advisor on Medicare Part D and provided strategic policy advice on issues ranging from clinical trial information disclosure to sales and marketing restrictions. Before joining Amylin in 2004, she held positions in the Public Policy and U.S. Human Health Public Affairs Departments of pharmaceutical industry leader Merck and Company, Inc. Ms. Ingargiola has also worked in both houses of Congress, including positions with the offices of U.S. Senator Robert G. Torricelli (D-NJ) and U.S. Representative Anna G. Eshoo (D-14-CA) of the House Energy and Commerce Committee. She began her career as an intern in the Clinton White House.
Memberships & Activities
Member, Young Leadership Network, hosted by the American League of Lobbyists (ALL).
Member, California Elected Women’s Association.
Past Delegate, Atlantic County, New Jersey Democratic Convention.
Member, Communication, Culture & Technology Alumni Council, Georgetown University.
Publications
Co-Author, "HHS Moves Forward With HITECH Privacy, Security Provisions," iHealthBeat, August 2, 2010.
Co-Author, "Stage 1 Meaningful Use Requirements Finalized Under HITECH EHR Incentive Program," BNA, Inc., July 2010.
Co-Author, "HITECH Revisited," California Healthcare Foundation, Colorado Health Foundation, and United Hospital Fund, June 2010.
Co-Author, "Health IT Law & Industry Report: Meaningful Use and Certification of Electronic Health Record Under the HITECH Medicare and Medicaid EHR Incentive Programs," BNA, Inc., January 2010.
Co-Author, "HITECH's State Health Information Exchange and Health IT Extension Programs: Providing Infrastructure and Support for Meaningful Use of EHRs," BNA, Inc., November 2009.
Co-Author, "The Impact of Federal Stimulus Funds on Oral Health Services in California," California Healthcare Foundation, August 2009.
Co-Author, "The Role of Local Governments in Administering Medicaid in New York," Medicaid Institute at the United Hospital Fund, August 2009.
Co-author, "State Regulation of De-Identified Health Information, How States Like New Hampshire are Getting It Wrong, Might Kill Healthcare's Golden Goose," BNA, April 2009.
Contributor, ?Recommendations for Standardized Consumer Consent Policies and Procedures for RHIOs in New York to Advance Interoperable Health Information Exchange to Improve Care,? New York State Department of Health, November 2008.
Co-Author, “E-Prescribing Mandate May Be Included in Medicare Package,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, May 23, 2008.
Co-Author, “E-Prescribing’s Dirty Little Secret – Secret Status Update on the DEA Controlled Substances Ban,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, May 5, 2008.
Summary, “Model Guidelines and Formulary Key Drug Types Version 4.0,” U.S. Pharmacopeia, February 2008.
“Key Elements of DRAFT 2009 Medicate: Advantage (MA), Medicare Advantage-Prescription Drug (MA-PD), Cost-Based Plan, and Prescription Drug Plan (PDP) Sponsors Call Letter (Part D Section,” Manatt Health Solutions Alert, January 17, 2008.
Contributor, “E-Prescribing...Has Its Time Finally Come?: E-Prescribing Heating Up at the National and State Levels,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, December 2007.
Co-Author, “Private Medicare Drug Plans: High Expenses and Low Rebates Increase the Costs of Medicare Drug Coverage,” Life Sciences Practice Group E-mail Alert, American Health Lawyers Association, October 16, 2007.
Co-Author, “Vaccine Administration and Access Update: Beneficiaries to Receive Greater Access to Vaccines in 2008,” Life Sciences Law & Industry Report 1(13), September 14, 2007.
Contributor, “CHI Hosts Annual Healthcare Policy Forum: The Information Technology-Enabled Movement to Achieve Value-Driven Healthcare,” California Healthcare Institute White Paper, August 2, 2007.
Co-Author, “Part D Formularies: The Ongoing Battleground between Access and Cost,” Chapter in Health Law Handbook, Thompson/West, May 2007.
Co-Author, “CMS Issues 2008 Part D Vaccine Guidance Summary,” Life Sciences Practice Group E-mail Alert, American Health Lawyers Association, May 15, 2007.
Co-Aauthor, “Summary of Baucus Proposed Legislation to Strike the Non-Interference Clause,” American Health Lawyers Association Practice Group E-mail Alert, April 11, 2007.
Co-Author, “New Developments in Part D Vaccine Administration and Access,” BNA's Health Plan & Provider Report , January 10, 2007.
“Governor’s Healthcare Focus Confirmed in State of the State Address and Reform Speech,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, January 2007.
Author, “Healthcare Headed for the Spotlight in California; Schwarzenegger Focusing on Coverage and Affordability,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, December 2006.
Contributor, “The Power to Help: U.S. Businesses Creating a Better Tomorrow,” a report to the President from the President's Export Council on U.S. Corporate Stewardship Around the World, Fall 2004.
